2003
Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma. J Clin Oncol. 2003;21(16):3051-9.
The utility of the in situ detection of T-cell receptor Beta rearrangements in cutaneous T-cell-dominant infiltrates. Diagn Mol Pathol. 2003;12(3):133-41.
CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol. 2003;27(2):141-9.
Analysis of user-satisfaction with the use of a teleconsultation system in oncology. Med Inform Internet Med. 2003;28(2):73-84.
Cutaneous vasculitis: a review. J Cutan Pathol. 2003;30(3):161-73.
The MDM2 RING finger is required for cell cycle-dependent regulation of its protein expression. FEBS Lett. 2003;544(1-3):218-22.
Eosinophilic variant of chronic myeloid leukemia with vascular complications. Leuk Lymphoma. 2003;44(9):1609-13.
Biomarkers in diagnostic obstetric and gynecologic pathology: a review. Adv Anat Pathol. 2003;10(2):55-68.
CUL-4A stimulates ubiquitylation and degradation of the HOXA9 homeodomain protein. EMBO J. 2003;22(22):6057-67.
NF-kappaB activation by protein kinase C isoforms and B-cell function. EMBO Rep. 2003;4(1):31-6.